from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1856c/-

LFCtreatmentdescriptionclass of inhibitor

1.066

Amikacinug/mL Amikacintranslation

1.673

Cap5-10ug/mL Capreomycintranslation

2.406

Rox10-50 ug/mL Roxithromycintranslation

0.815

SM2-5 ug/mL Streptomycintranslation

1.824

Tet5-10 ug/mL Tetracyclinetranslation

0.287

Rif0.2-5ug/mL Rifampicintranscription

0.008

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.476

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.013

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.545

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.675

Clofazimine10-13 ug/mL Clofaziminerespiration

0.273

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.057

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.054

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.423

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.569

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.910

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.971

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.008

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.310

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.940

KCN5-20 ug/mL Potassium cyaniderespiration

0.529

NaN30.2-2 mM Sodium aziderespiration

0.263

Nigericin50 uM Nigericinrespiration

-0.202

TRC10-150 ug/mL Triclosanrespiration

-1.053

TRZ10-25 ug/mL Thioridazinerespiration

0.534

Valinomycin0.5-10 uM Valinomycinrespiration

0.345

ZnSO42 mM ZnSO4respiration

-0.084

menadione6-10 ug/mL Menadionerespiration

-0.378

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.078

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.037

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.064

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.352

NRP_1Non-replicating persistence stage 1dosRassociated

0.489

Amp0.2mg/mL AmpicillincellWall

0.519

Cephalexin20-100 ug/mL CephalexincellWall

-1.221

Cerulenin0.32-5 ug/mL CerulenincellWall

0.030

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.641

EMB10-20 ug/mL EthambutolcellWall

2.214

Eta12-40 ug/mL EthionamidecellWall

1.894

INH0.2-0.4 ug/mL IsoniazidcellWall

1.153

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.204

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.145

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.368

BZA0.12 mg/mL BenzamidearomaticAmides

0.398

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.045

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.080

H2O24 mM hydrogen peroxideDNAdamaging

-0.544

Levo10 ug/mL LevofloxacinDNAdamaging

-0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.792

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.563

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.332

UVUV-irradiationDNAdamaging

-1.175

ARP41-4 ug/mL Antitubercular compound ARP4?

0.119

Antimycin12.5-50 ug/mL Antimycin A?

0.329

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.185

PA_110-50 ug/mL Antitubercular compound PA-1?

0.014

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.213

PA8240.2-2 ug/mL PA-824?

-1.124

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.432

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.010

Verapamil50 uM Verapamil?

-0.339

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.008

methoxatin10-20 ug/mL Methoxatin?